Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Alger Health Sciences Fund

+ Add to Watchlist

AHSCX:US

21.02 USD 0.000.00%

As of 09:29:30 ET on 05/22/2015.

Snapshot for Alger Health Sciences Fund (AHSCX)

Year To Date: +12.83% 3-Month: +5.73% 3-Year: +24.97% 52-Week Range: 16.07 - 21.43
1-Month: -0.52% 1-Year: +33.40% 5-Year: +19.22% Beta vs SPX: 0.93

Mutual Fund Chart for AHSCX

No chart data available.
  • AHSCX:US 21.02
  • 1M
  • 1Y
Interactive AHSCX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for AHSCX

Alger Health Sciences Fund is an open-end fund incorporated in the USA. The Fund seeks long-term capital appreciation. The Fund invest in equity securities of companies of any market capitalization that are engaged in the health sciences sector.

Inception Date: 05-01-2002 Telephone: 1-800-992-3863
Managers: DANIEL C CHUNG "DAN" / TERESA MCROBERTS
Web Site: www.alger.com

Fundamentals for AHSCX

NAV (on 2015-05-22) 21.02
Assets (M) (on 2015-04-30) 206.03
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 50.00

Dividends for AHSCX

Dividend Type Short Term Cap Gain
Dividend Frequency Annual
Last Dividend Net (on 2014-12-18) 1.52
Dividend Yield (ttm) 25.86

Fees & Expenses for AHSCX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.81
Redemption Fee 2.00
12b1 Fee 1.00
Expense Ratio 2.10

Top Fund Holdings for AHSCX

Filing Date: 02/28/2015
Name Position Value % of Total
Actavis plc 51,267 14,937,153 7.080%
Biogen Inc 25,000 10,239,750 4.854%
Gilead Sciences Inc 95,450 9,881,939 4.684%
Shire PLC 24,350 5,890,509 2.792%
HCA Holdings Inc 80,600 5,766,124 2.733%
Cigna Corp 44,900 5,461,187 2.589%
Tenet Healthcare Corp 116,600 5,398,580 2.559%
Mallinckrodt PLC 43,100 5,030,632 2.384%
Intercept Pharmaceuticals Inc 22,600 5,002,962 2.371%
Celgene Corp 36,700 4,460,151 2.114%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil